Cognitive Neuroscience, Serotonin and Depression Flashcards

1
Q

are attention biases more typical of depression or anxiety?

A

anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

attention biases in depression?

A

characterised by biases in maintaining/shifting attention = difficulties for depressed people to disengage from negative material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does fMRI (functional MRI) work?

A

detecting the changes in blood oxygenation and flow that occur in response to neural activity – when a brain area is more active it consumes more oxygen and to meet this increased demand
blood flow increases to the active are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

attention biases: neurofunctional abnormalities

A

sustained amygdala response to negative stimuli
Prefrontal cortex:
• perigenual anterior cingulate cortex (ACC) (BA 24, 25, and 32)
appears to mediate negative attentional biases
• lateral inferior frontal cortex associated with the impaired ability
to divert attention from task-irrelevant negative information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

memory biases: depression

A

Preferential recall of negative compared to positive material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

apart from depressed people, memory biases also present in?

A

individuals at risk (neuroticism) and in recovered depressed individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

apart from depressed and anxious people, attention biases present in?

A

remitted depressed adults and high risk individuals: attention biases in healthy girls at high risk for depression due to maternal
psychopathology but not in never-depressed individuals with high
neuroticism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

perceptual biases and facial expression recognition in depression

A

^ recognition -ve faces, decreased recognition of +ve faces

reduced recognition of all basic emotions except for sadness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

who is at risk of perceptual biases?

A

in neuroticism reduced recognition of happy faces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Facial expression processing:

neurofunctional abnormalities

A

Enhanced amygdala response to negative faces, even in the absence of awareness but not always replicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

first line depression medication

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

standard antidepressants have a delay in onset of action of at least _______ after treatment begins?

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prediction of clinical response to SSRI

A

Elevated baseline ACC activity in depressed patients during tasks that probe affective circuitry
early decreased brain (incl. amygdala) response to fear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

facial expression recognition biases are associated with what?

A

dysfunctional amygdala and ACC activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does the ‘monoamine deficiency hypothesis’ postulate?

A
that depressive symptoms arise from insufficient levels of monoamine
neurotransmitters serotonin (or 5-hydroxytryptamine , 5-HT),
norepinephrine, and/or dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

list indirect evidence for 5-HT hypofunction in depression

A

5HT depletion by reserpine can cause depression, useful antidepressants ^[monoamine], reduced 5HT levels in brainstem of those who commit suicide, ^monoamin oxidas A in MDD, tryptophan depletion triggers relapse in MDD

17
Q

list methods to investigate brain pharmacology

A

PET

fMRI

18
Q

how to approach quantifying dopamine receptors?

A

use [11C]raclopride as a ligand for amphetamine challenge

19
Q

method for measuring release of cerebral 5HT

A

using a 5-HT2A agonist PET tracer, amphetamine as pharma challenge